MedTrace Logo

Retrospective Modulus ALIF Study

NCT05566704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2025-12-22

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.

Conditions

  • Degenerative Disc Disease
  • Spondylolisthesis
  • Stenosis

Interventions

DEVICE

Modulus ALIF System

The Modulus ALIF System is designed to address lumbar pathologies utilizing interbody placement through an anterior or anterolateral surgical approach. The Modulus ALIF System is an interfixated interbody system available in various shapes and sizes to suit the individual pathology and anatomical conditions of the patient.

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kyle Malone, MS · Globus Medical

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-18
Primary Completion
2022-10-15
Completion
2024-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05566704 on ClinicalTrials.gov